Copper enzyme activities in cystic fibrosis before and after copper supplementation plus or minus zinc

Metabolism: Clinical and Experimental

Volumn 53, Issue 1, 2004, Pages 37-41

  Best, Kristin ^a   McCoy, Karen ^a   Gemma, Susan ^a   DiSilvestro, Robert A ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMINE OXIDASE (COPPER CONTAINING); CERULOPLASMIN; COPPER; GLYCINATE COPPER; MULTIVITAMIN; PLACEBO; RETINOL; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN K GROUP; ZINC; ZINC GLYCINATE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPPER DEFICIENCY; COPPER METABOLISM; CYSTIC FIBROSIS; DRUG EFFECT; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ERYTHROCYTE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS INSUFFICIENCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SENSITIVITY ANALYSIS; ZINC DEFICIENCY;

EID: 0347946727     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.07.017     Document Type: Article

References (38)

1. Ratjen F: Changes in strategies for optimal antibacterial therapy in cystic fibrosis. Int J Antimicrob Agents 17:93-96, 2001
2. Percival SS: Copper and immunity. Am J Clin Nutr 67:1064S-1068S, 1998
3. Howell JMC, Gawthorne JM: Copper in Animals and Man. Boca Raton, FL, CRC, 1987
4. Brown RK, Wyatt H, Price JF, et al.: Pulmonary dysfunction in cystic fibrosis is associated with oxidative stress. Eur Respir J 9:334-339, 1996
5. Percival SS, Bowser E, Wagner M: Reduced copper enzyme activities in blood cells of children with cystic fibrosis. Am J Clin Nutr 62:633-638, 1995
6. Percival SS, Kauwell GP, Bowser E, et al.: Altered copper status in adult men with cystic fibrosis. J Am Coll Nutr 18:614-619, 1998
7. DiSilvestro R, Marten J, Skehan M: Effects of copper supplementation on ceruloplasmin and copper-zinc superoxide dismutase in free-living rheumatoid arthritis patients. J Am Coll Nutr 11:177-180, 1992
8. Jones AA, DiSilvestro RA, Coleman M, et al.: Copper supplementation of adult men: Effects on blood copper enzyme activities and indicators of cardiovascular disease risk. Metabolism 46:1380-1383, 1997
9. DiSilvestro R, Marten J: Effects of inflammation and copper intake on rat liver and erythrocyte Cu-Zn superoxide dismutase activity levels. J Nutr 120:1223-1227, 1990
10. DiSilvestro RA: Effects of copper intake, inflammation and copper injection on rat serum ceruloplasmin activity levels. Nutr Res 10:355-358, 1990
11. Wagner TL, DiSilvestro RA, Medeiros DM: Marginal copper intake and inflammation effects on copper enzyme activities in rats. J Trace Elem Exp Med 8:41-46, 1995
12. DiSilvestro RA, Jones AA, Smith D, et al.: Plasma diamine oxidase activities in renal dialysis patients, a human with spontaneous copper deficiency and marginally copper deficient rats. Clin Biochem 30:559-563, 1997
13. Reiser S, Smith J, Mertz W: Indices of copper status in humans consuming a typical American diet containing either fructose or starch. Am J Clin Nutr 42:242-251, 1985
14. Milne DB, Davis CD, Nielsen FH: Low dietary zinc alters indices of copper function and status in postmenopausal women. Nutrition 17:701-708, 2001
15. Milne DB, Nielsen FH: Effects of a diet low in copper on copper-status indicators in postmenopausal women. Am J Clin Nutr 63:358-364, 1996
16. Solomons NW, Wagonfeld JB, Rieger C, et al.: Some biochemical indices of nutrition in treated cystic fibrosis. Am J Clin Nutr 34:462-474, 1981
17. Klevay LM: Re: "Serum copper and the risk of acute myocardial infarction: A prospective population study in men in eastern Finland." Am J Epidemiol 135:832-834, 1992
18. Kehoe CA, Turley E, Bonham MP, et al.: Response of putative indices of copper status to copper supplementation in human subjects. Br J Nutr 84:151-156, 2000
19. Kehoe CA, Faughnan MS, Gilmore WS, et al.: Plasma diamine oxidase activity is greater in copper-adequate than copper-marginal or copper-deficient rats. J Nutr 130:30-33, 2000
20. Mocchegiani E, Provinciali M, Di Stefano G, et al.: Role of the low zinc bioavailability on cellular immune effectiveness in cystic fibrosis. Clin Immunol Immunopathol 75:214-224, 1995
21. Rock E, Mazur A, O'Connor JM, et al.: The effect of copper supplementation on red blood cell oxidizability and plasma antioxidants in middle-aged healthy volunteers. Free Radic Biol Med 28:324-329, 2000
22. Rice E: Standardization of ceruloplasmin activity in terms of international enzyme units. Anal Biochem 3:452-456, 1962
23. Takagi K, Nakao M, Ogura Y: Sensitive colorimetric assay of serum diamine oxidase. Clin Chim Acta 226:67-75, 1994
24. Holtzman NA, Gaumnitz BM: Studies on the rate of release and turnover of ceruloplasmin and apoceruloplasmin in rat plasma. J Biol Chem 245:2354-2358, 1970
25. Wolvekamp MC, De Bruin RW: Diamine oxidase: An overview of historical, biochemical and functional aspects. Dig Dis 12:2-14, 1994
26. Salo DC, Pacifici RE, Lin SW, et al.: Superoxide dismutase undergoes proteolysis and fragmentation following oxidative modification and inactivation. J Biol Chem 265:11919-11927, 1990
27. Turnlund JR, Scott KC, Peiffer GL, et al.: Copper status of young men consuming a low-copper diet. Am J Clin Nutr 65:72-78, 1997
28. Weller PH: Implications of early inflammation and infection in cystic fibrosis: A review of new and potential interventions. Pediatr Pulmonol 24:143-145, 1997
29. Emenaker NJ, DiSilvestro RA, Nahman NS, et al.: Copper-related blood parameters in kidney dialysis patients. Am J Clin Nutr 64:757-760, 1996
30. Jacob RA, Skala JH, Omaye ST, et al.: Effect of varying ascorbic acid intakes on copper absorption and ceruloplasmin levels of young men. J Nutr 117:2109-2115, 1987
31. Joung H, DiSilvestro RA, Burge JC, et al.: Zinc and copper-related blood parameters in male trauma patients. Nutr Res 18:693-701, 1998
32. DiSilvestro RA: Copper supplementation effects on oxidant stress and bone turnover markers in young adult women. FASEB J 17:A1129, 2003
33. Larson JE, Cohen JC: Cystic fibrosis revisited. Mol Genet Metab 71:470-477, 2000
34. Condomina J, Zornoza-Sabina T, Granero L, et al.: Kinetics of zinc transport in vitro in rat small intestine and colon: Interaction with copper. Eur J Pharm Sci 16:289-295, 2002
35. Davis-Kaplan R, Askwith CC, Bengtzen AC, et al.: Chloride is an allosteric effector of copper assembly for the yeast multicopper oxidase Fet3p: An unexpected role for intracellular chloride channels. Proc Natl Acad Sci USA 95:13641-13645, 1998
36. Sandstead HH: Requirements and toxicity of essential trace elements, illustrated by zinc and copper. Am J Clin Nutr 61:621S-624S, 1995
37. L'Abbe MR, Fisher PW: The effects of dietary zinc on the activity of copper-requiring metalloenzymes in the rat. J Nutr 114:823-828, 1984
38. Bettger WJ, Fish TJ, O'Dell BL: Effects of copper and zinc status of rats on erythrocyte stability and superoxide dismutase activity. Proc Soc Exp Biol Med 158:279-282, 1978